Guangqian Zhou

3.7k total citations
100 papers, 2.9k citations indexed

About

Guangqian Zhou is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Guangqian Zhou has authored 100 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 29 papers in Genetics and 18 papers in Rheumatology. Recurrent topics in Guangqian Zhou's work include Mesenchymal stem cell research (28 papers), Osteoarthritis Treatment and Mechanisms (15 papers) and Bone Metabolism and Diseases (13 papers). Guangqian Zhou is often cited by papers focused on Mesenchymal stem cell research (28 papers), Osteoarthritis Treatment and Mechanisms (15 papers) and Bone Metabolism and Diseases (13 papers). Guangqian Zhou collaborates with scholars based in China, Hong Kong and United States. Guangqian Zhou's co-authors include Yubin Deng, Ye Wang, Kmc Cheung, Songlin Peng, K.D.K. Luk, Tianfu Wang, Hua Liao, William W. Lu, Gang Li and Zhongjun Zhou and has published in prestigious journals such as PLoS ONE, Biomaterials and The Science of The Total Environment.

In The Last Decade

Guangqian Zhou

99 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangqian Zhou China 32 996 762 671 549 432 100 2.9k
A.T. Brini Italy 37 1.4k 1.4× 1.2k 1.5× 705 1.1× 363 0.7× 380 0.9× 118 3.8k
Byung Hyune Choi South Korea 36 941 0.9× 875 1.1× 929 1.4× 646 1.2× 858 2.0× 125 3.7k
Gianluca D’Ippolito United States 19 1.2k 1.2× 1.2k 1.6× 718 1.1× 375 0.7× 298 0.7× 33 2.7k
Lin Song China 25 1.1k 1.1× 941 1.2× 567 0.8× 416 0.8× 246 0.6× 53 2.8k
Nicholas R. Forsyth United Kingdom 30 1.5k 1.5× 618 0.8× 810 1.2× 582 1.1× 161 0.4× 102 3.8k
Xiao‐Dong Chen United States 31 1.4k 1.4× 1.0k 1.4× 1.1k 1.6× 622 1.1× 497 1.2× 66 3.9k
Benedetta Mazzanti Italy 31 858 0.9× 591 0.8× 621 0.9× 277 0.5× 123 0.3× 72 2.4k
Erdal Karaöz Türkiye 31 816 0.8× 1.4k 1.8× 989 1.5× 264 0.5× 188 0.4× 155 3.1k
Ben A. Scheven United Kingdom 29 1.4k 1.4× 729 1.0× 410 0.6× 395 0.7× 383 0.9× 66 3.1k

Countries citing papers authored by Guangqian Zhou

Since Specialization
Citations

This map shows the geographic impact of Guangqian Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangqian Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangqian Zhou more than expected).

Fields of papers citing papers by Guangqian Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangqian Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangqian Zhou. The network helps show where Guangqian Zhou may publish in the future.

Co-authorship network of co-authors of Guangqian Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Guangqian Zhou. A scholar is included among the top collaborators of Guangqian Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangqian Zhou. Guangqian Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaokun, Guangqian Zhou, Junjun Xiong, et al.. (2025). H4K12 Lactylation Activated‐Spp1 in Reprogrammed Microglia Improves Functional Recovery After Spinal Cord Injury. CNS Neuroscience & Therapeutics. 31(2). e70232–e70232. 3 indexed citations
2.
Liu, Jie, et al.. (2024). Establishment and validation of an efficient method for the 3D culture of osteoclasts in vitro. Journal of Dentistry. 144. 104957–104957. 2 indexed citations
3.
Ren, Yu, Mingzhu Li, Peng Yang, et al.. (2024). An object detection-based model for automated screening of stem-cells senescence during drug screening. Neural Networks. 183. 106940–106940.
4.
Padhiar, Arshad Ahmed, Zhu Li, Wei Shu, et al.. (2024). MAM‐STAT3‐Driven Mitochondrial Ca+2 Upregulation Contributes to Immunosenescence in Type A Mandibuloacral Dysplasia Patients. Advanced Science. 12(5). e2407398–e2407398. 2 indexed citations
5.
Zhang, Shuai, et al.. (2023). Integrative Analysis of Machine Learning and Molecule Docking Simulations for Ischemic Stroke Diagnosis and Therapy. Molecules. 28(23). 7704–7704. 6 indexed citations
6.
Zhang, Juan, Zhu Li, Zhongyuan He, et al.. (2023). Rps6ka2 enhances iMSC chondrogenic differentiation to attenuate knee osteoarthritis through articular cartilage regeneration in mice. Biochemical and Biophysical Research Communications. 663. 61–70. 1 indexed citations
7.
Chen, Junhui, Jun Li, Dezhi Li, et al.. (2021). Strontium gluconate potently promotes osteoblast development and restores bone formation in glucocorticoid-induced osteoporosis rats. Biochemical and Biophysical Research Communications. 554. 33–40. 7 indexed citations
8.
Yue, Guanghui, et al.. (2021). Quality evaluation of induced pluripotent stem cell colonies by fusing multi-source features. Computer Methods and Programs in Biomedicine. 208. 106235–106235. 7 indexed citations
9.
Guo, Peng, Penghui Zhang, Zhongyuan He, et al.. (2021). A single-cell transcriptome of mesenchymal stromal cells to fabricate bioactive hydroxyapatite materials for bone regeneration. Bioactive Materials. 9. 281–298. 20 indexed citations
10.
Liu, Jia, Kang Li, Lin Cheng, et al.. (2020). A high-throughput drug screening strategy against coronaviruses. International Journal of Infectious Diseases. 103. 300–304. 13 indexed citations
11.
Wang, Ting, et al.. (2020). Donor genetic backgrounds contribute to the functional heterogeneity of stem cells and clinical outcomes. Stem Cells Translational Medicine. 9(12). 1495–1499. 37 indexed citations
12.
Zhang, Shuai, Wei Zhang, & Guangqian Zhou. (2019). Extended Risk Factors for Stroke Prevention. Journal of the National Medical Association. 111(4). 447–456. 22 indexed citations
13.
Wang, Tingyu, Shan Li, Dan Yi, et al.. (2018). CHIP regulates bone mass by targeting multiple TRAF family members in bone marrow stromal cells. Bone Research. 6(1). 10–10. 22 indexed citations
14.
Kang, Ran, Yan Zhou, Shuang Tan, et al.. (2015). Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Research & Therapy. 6(1). 144–144. 99 indexed citations
15.
Neshati, Zeinab, Jia Liu, Guangqian Zhou, Martin J. Schalij, & Antoine A.F. de Vries. (2014). Development of a Lentivirus Vector-Based Assay for Non-Destructive Monitoring of Cell Fusion Activity. PLoS ONE. 9(7). e102433–e102433. 2 indexed citations
16.
Liu, Jia, Baohua Liu, Huiling Zheng, et al.. (2014). HP1α mediates defective heterochromatin repair and accelerates senescence inZmpste24-deficient cells. Cell Cycle. 13(8). 1237–1247. 14 indexed citations
17.
Lv, Fengjuan, Minmin Lu, Kmc Cheung, Vyl Leung, & Guangqian Zhou. (2012). Intrinsic Properties of Mesemchymal Stem Cells from Human Bone Marrow, Umbilical Cord and Umbilical Cord Blood Comparing the Different Sources of MSC. Current Stem Cell Research & Therapy. 7(6). 389–399. 45 indexed citations
18.
Huang, Shishu, Vyl Leung, Songlin Peng, et al.. (2011). Developmental Definition of MSCs: New Insights Into Pending Questions. Cellular Reprogramming. 13(6). 465–472. 24 indexed citations
19.
Huang, Shishu, et al.. (2011). Stem Cell-Based Approaches for Intervertebral Disc Regeneration. Current Stem Cell Research & Therapy. 6(4). 317–326. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.T. Brini Breakdown of academic impact, for papers by Byung Hyune Choi Breakdown of academic impact, for papers by Gianluca D’Ippolito Breakdown of academic impact, for papers by Lin Song Breakdown of academic impact, for papers by Nicholas R. Forsyth Breakdown of academic impact, for papers by Xiao‐Dong Chen Breakdown of academic impact, for papers by Benedetta Mazzanti Breakdown of academic impact, for papers by Erdal Karaöz Breakdown of academic impact, for papers by Ben A. Scheven
Rankless by CCL
2026